Question 1

Does Millennium Management own KNTE stock?

Accepted Answer

As of its Q1 2024 13F, Millennium Management held 267,355 shares of KNTE (Kinnate Biopharma), worth $711,164.

Question 2

How many shares of KNTE does Millennium Management own?

Accepted Answer

As of its Q1 2024 13F, Millennium Management held 267,355 shares of KNTE (Kinnate Biopharma).

Question 3

What is Millennium Management's KNTE position worth?

Accepted Answer

As of its Q1 2024 13F, Millennium Management's KNTE position was worth $711,164.

Question 4

When did Millennium Management first buy KNTE?

Accepted Answer

Millennium Management already held KNTE in its Q4 2020 13F, the earliest on record, and listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q1	Decreased	267,355	-52.7%	$711,164	0.0%	—	0
2023-Q4	Increased	564,932	+1.4%	$1.3M	0.0%	—	26
2023-Q3	Decreased	557,258	-38.2%	$780,161	0.0%	—	0
2023-Q2	New	902,242	-	$2.7M	0.0%	—	36
2022-Q4	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q3	New	78,889	-	$943,000	0.0%	—	35
2022-Q2	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q1	New	13,683	-	$154,000	0.0%	—	31
2021-Q4	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q3	New	118,734	-	$2.7M	0.0%	—	36
2021-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2020-Q4	New	89,796	-	$3.6M	0.0%	—	37

KNTE13 quarters

KNTE
13 quarters